Stock A260660 KOREA ARLICO PHARM CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Korea Arlico Pharm Co.,Ltd.

Equities

A260660

KR7260660006

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-06-27 pm EDT 		5-day change 1st Jan Change
4,800 KRW -0.10% Intraday chart for Korea Arlico Pharm Co.,Ltd. -1.84% -15.79%
2023 Korea Arlico Pharm Co.,Ltd. announced that it has received KRW 10 billion in funding CI
2023 Korea Arlico Pharm Co.,Ltd. announced that it expects to receive KRW 10 billion in funding CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Korea Arlico Pharm Co.,Ltd. announced that it has received KRW 10 billion in funding
CI
Korea Arlico Pharm Co.,Ltd. announced that it expects to receive KRW 10 billion in funding
CI
Korea Arlico Pharm Co.,Ltd. announced that it has received KRW 10 billion in funding from Hanyang Securities Co., Ltd., Investment Arm, NH Hedge Co., Ltd., SUSUNG ASSET MANAGEMENT Co., Ltd., Infinity Investment Advisory Co.,Ltd., and other investors
CI
Korea Arlico Pharm Co.,Ltd. announced that it expects to receive KRW 10 billion in funding from Hanyang Securities Co., Ltd., Investment Arm, NH Hedge Co., Ltd., SUSUNG ASSET MANAGEMENT Co., Ltd., Infinity Investment Advisory Co.,Ltd. and other investors
CI
Tranche Update on Korea Arlico Pharm Co.,Ltd.'s Equity Buyback Plan announced on October 6, 2021.
CI
Korea Arlico Pharm Co.,Ltd.'s Equity Buyback announced on October 6, 2021, has closed with 64,000 shares, representing 0.42% for KRW 496.14 million.
CI
Korea Arlico Pharm Co.,Ltd. announces an Equity Buyback for 64,000 shares.
CI
Korea Arlico Pharm Co.,Ltd. authorizes a Buyback Plan.
CI
An unknown buyer acquired 2.5% stake in Korea Arlico Pharm Co.,Ltd. from Hanggu Lee for KRW 3.5 billion.
CI
Tranche Update on Korea Arlico Pharm Co.,Ltd.'s Equity Buyback Plan announced on March 13, 2020.
CI
Korea Arlico Pharm Co.,Ltd.'s Equity Buyback announced on March 13, 2020, has closed with 102,400 shares, representing 1.07% for KRW 837.77 million.
CI
Korea Arlico Pharm Co.,Ltd. announces an Equity Buyback for 102,040 shares.
CI
Korea Arlico Pharm Co.,Ltd. authorizes a Buyback Plan.
CI
Korea Arlico Pharm Co.,Ltd.'s Equity Buyback announced on June 3, 2019, has expired.
CI
Tranche Update on Korea Arlico Pharm Co.,Ltd.'s Equity Buyback Plan announced on June 3, 2019.
CI
Korea Arlico Pharm Co.,Ltd. announces an Equity Buyback for KRW 1,000 million worth of its shares.
CI
Korea Arlico Pharm Co.,Ltd. authorizes a Buyback Plan.
CI
Tranche Update on Korea Arlico Pharm Co.,Ltd.'s Equity Buyback Plan announced on August 20, 2018.
CI
Tranche Update on Korea Arlico Pharm Co.,Ltd.'s Equity Buyback Plan announced on August 20, 2018.
CI
Tranche Update on Korea Arlico Pharm Co.,Ltd.'s Equity Buyback Plan announced on August 20, 2018.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A260660 Stock
  4. News Korea Arlico Pharm Co.,Ltd.